5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.59▼ | 0.60▼ | 0.60▼ | 0.61▼ | 0.55▲ |
MA10 | 0.61▼ | 0.61▼ | 0.61▼ | 0.59▼ | 0.54▲ |
MA20 | 0.60▼ | 0.60▼ | 0.60▼ | 0.56▲ | 0.49▲ |
MA50 | 0.60▼ | 0.59▼ | 0.57▲ | 0.54▲ | 0.59▼ |
MA100 | 0.60▼ | 0.55▲ | 0.54▲ | 0.49▲ | 1.60▼ |
MA200 | 0.55▲ | 0.54▲ | 0.54▲ | 0.58▲ | 4.06▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.004▼ | -0.005▼ | 0.004▲ | 0.030▲ |
RSI | 41.735▼ | 45.335▼ | 47.056▼ | 55.813▲ | 52.156▲ |
STOCH | 34.195 | 50.862 | 50.862 | 70.462 | 49.242 |
WILL %R | -90.110▼ | -90.110▼ | -90.110▼ | -34.971 | -45.329 |
CCI | -95.020 | -116.732▼ | -112.808▼ | 36.951 | 167.650▲ |
MA | $PHGE Price Crossed Below MA(7) | Set Alert |
Friday, October 17, 2025 05:49 AM
BiomX believes that it has fully addressed the FDA’s queries related to the third-party nebulizer used to deliver BX004, which are narrow in ...
|
Thursday, June 26, 2025 05:31 AM
BiomX’s recent Phase 2 DANCE trial results help explain the military’s confidence. The study of 41 patients with diabetic foot osteomyelitis showed: Statistically significant reduction in ulcer size ...
|
Monday, June 16, 2025 12:04 PM
BiomX Inc. (NYSE: PHGE)* has achieved what Big Pharma couldn't accomplish in over 20 years — successful clinical trials using viruses to treat life-threatening infections that no longer respond to ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
17/10/25 | 0.60 | 0.60 | 0.5865 | 0.5865 | 275,847 |
16/10/25 | 0.623 | 0.63 | 0.573 | 0.591 | 289,100 |
15/10/25 | 0.64 | 0.6467 | 0.6196 | 0.6237 | 270,259 |
14/10/25 | 0.604 | 0.64 | 0.585 | 0.63 | 289,100 |
13/10/25 | 0.647 | 0.647 | 0.58 | 0.605 | 350,500 |
10/10/25 | 0.635 | 0.635 | 0.57 | 0.584 | 350,500 |
09/10/25 | 0.58 | 0.631 | 0.577 | 0.62 | 675,300 |
08/10/25 | 0.579 | 0.595 | 0.541 | 0.58 | 368,500 |
07/10/25 | 0.58 | 0.595 | 0.541 | 0.569 | 1,165,000 |
06/10/25 | 0.525 | 0.558 | 0.497 | 0.549 | 1,073,300 |
|
|
||||
|
|
||||
|
|